Please log in to determine if you are eligible to purchase PT Programs.
CAP/ACMG MOLECULAR GENETICS - MGL3
MGL3
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Disease/Gene Challenges per Shipment Number of Shipments
BRCA1/2 3 Two shipments per year
Connexin 26 3
Multiple endocrine neoplasia type 2 (MEN2) 3

Additional Information

  • The BRCA1/2 program is designed for laboratories testing for the three Ashkenazi Jewish founder mutations.
  • The Prader-Willi/Angelman syndrome program is designed for laboratories using methylation techniques for analysis.

Program Information

  • Three 50.0‑μg extracted DNA specimens

Shipping Schedule

  • Shipment A: March 25
  • Shipment B: October 15